Inhibition of adrenergic function in the treatment of hypertension.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001337:Autonomic Agents / Q000009:adverse effects / Q000494:pharmacology; D001949:Bretylium Compounds / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D003864:Depression, Chemical; D005725:Ganglia, Autonomic / Q000187:drug effects; D005730:Ganglionic Blockers / Q000494:pharmacology / Q000627:therapeutic use; D006145:Guanethidine / Q000494:pharmacology; D006439:Hemodynamics / Q000187:drug effects; D006973:Hypertension / Q000188:drug therapy*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011926:Rauwolfia / Q000494:pharmacology; D046948:Secologanin Tryptamine Alkaloids / Q000494:pharmacology; D013565:Sympatholytics / Q000009:adverse effects / Q000494:pharmacology*; D014703:Veratrum / Q000494:pharmacology
D000959:Antihypertensive Agents; D001337:Autonomic Agents; D001949:Bretylium Compounds; D005730:Ganglionic Blockers; D008996:Monoamine Oxidase Inhibitors; D046948:Secologanin Tryptamine Alkaloids; D013565:Sympatholytics; D003000:Clonidine; D006145:Guanethidine